Literature DB >> 15128608

Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study.

Danielle Laurin1, Kamal H Masaki, Daniel J Foley, Lon R White, Lenore J Launer.   

Abstract

Antioxidants have been hypothesized to protect against Alzheimer's disease, but studies conducted in late life have been inconsistent. Risk factors measured in midlife may better predict dementia in late life because they are less affected by the disease process. The authors examined the association of midlife dietary intake of antioxidants to late-life dementia and its subtypes. Data were obtained from the Honolulu-Asia Aging Study, a prospective community-based study of Japanese-American men who were aged 45-68 years in 1965-1968, when a 24-hour dietary recall was administered. The analysis included 2,459 men with complete dietary data who were dementia-free at the first assessment in 1991-1993 and were examined up to two times for dementia between 1991 and 1999. The sample included 235 incident cases of dementia (102 cases of Alzheimer's disease, 38 cases of Alzheimer's disease with contributing cerebrovascular disease, and 44 cases of vascular dementia). Relative risks by quartile of intake were calculated using Cox proportional hazards models with age as the time scale, after adjustment for sociodemographic and lifestyle factors, cardiovascular risk factors, other dietary constituents, and apolipoprotein E e4. Intakes of beta-carotene, flavonoids, and vitamins E and C were not associated with the risk of dementia or its subtypes. This analysis suggests that midlife dietary intake of antioxidants does not modify the risk of late-life dementia or its most prevalent subtypes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128608     DOI: 10.1093/aje/kwh124

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  59 in total

1.  Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliation.

Authors:  Janine K Cataldo; Judith J Prochaska; Stanton A Glantz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  Fruit and vegetable juices and Alzheimer's disease: the Kame Project.

Authors:  Qi Dai; Amy R Borenstein; Yougui Wu; James C Jackson; Eric B Larson
Journal:  Am J Med       Date:  2006-09       Impact factor: 4.965

3.  Nutrition and aging. The Carla Workshop.

Authors:  G Abellan van Kan; G Gambassi; L C P G M de Groot; S Andrieu; T Cederholm; E André; J P Caubère; J P Bonjour; P Ritz; A Salva; A Sinclair; B Vellas; J Daydé; J Deregnaucourt; C Latgé
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

Review 4.  Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Biochem Pharmacol       Date:  2014-01-04       Impact factor: 5.858

Review 5.  Diet, cognition, and Alzheimer's disease: food for thought.

Authors:  Ane Otaegui-Arrazola; Pilar Amiano; Ana Elbusto; Elena Urdaneta; Pablo Martínez-Lage
Journal:  Eur J Nutr       Date:  2013-07-27       Impact factor: 5.614

Review 6.  Dietary antioxidants, cognitive function and dementia--a systematic review.

Authors:  Georgina E Crichton; Janet Bryan; Karen J Murphy
Journal:  Plant Foods Hum Nutr       Date:  2013-09       Impact factor: 3.921

7.  Progress in the development of new drugs in Alzheimer's disease.

Authors:  Antoine Piau; F Nourhashémi; C Hein; C Caillaud; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

8.  Vitamin E use is associated with improved survival in an Alzheimer's disease cohort.

Authors:  Valory N Pavlik; Rachelle S Doody; Susan D Rountree; Eveleen J Darby
Journal:  Dement Geriatr Cogn Disord       Date:  2009-12-10       Impact factor: 2.959

Review 9.  Antioxidants in central nervous system diseases: preclinical promise and translational challenges.

Authors:  Chandrashekhar D Kamat; Sunyana Gadal; Molina Mhatre; Kelly S Williamson; Quentin N Pye; Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2008-11       Impact factor: 4.472

Review 10.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.